Market Narratives
Market themes driving price action · Updated Jul 26, 2026
Roku's FCF growth
An article belongs to this narrative if it discusses Roku's expected free cash flow growth.
Shell acquires ARC Resources
An article belongs to this narrative if it is about Shell's acquisition of ARC Resources.
PENG price target raised by Rosenblatt
An article belongs to this narrative if it discusses Rosenblatt raising its price target for Penguin Solutions, Inc.
IMAX insider selling shares
An article belongs to this narrative if it discusses IMAX insider selling shares.
LRN Q3 Earnings Drop
An article belongs to this narrative if it discusses Stride, Inc.'s Q3 earnings decline.
Jefferies' bullish Twilio stock outlook
An article belongs to this narrative if it discusses Jefferies' upgraded rating and bullish outlook for Twilio stock.
Puma executive changes
An article belongs to this narrative if it discusses executive changes at Puma.
CLX price target reduction
An article belongs to this narrative if it discusses the reduction of Clorox's price target by Jefferies.
Valero Energy's strong quarterly results
An article belongs to this narrative if it discusses Valero Energy's strong quarterly financial results.
HTIIQ record full-year revenue and guidance
An article belongs to this narrative if it discusses Health In Tech's full-year earnings, revenue growth, or guidance.
AMD earnings miss on weak personnel services
An article belongs to this narrative if it discusses AMD's earnings report with a focus on weak personnel services segment.
Simpson Manufacturing investment potential
An article belongs to this narrative if it discusses the investment potential of Simpson Manufacturing.
Cigna CEO succession
An article belongs to this narrative if it discusses the changing of the guard at the CEO position in the health insurance industry.
Woolworths acquires In2Food
An article belongs to this narrative if it discusses Woolworths' acquisition of private-label supplier In2Food in South Africa.
RARE DTX301 Phase 3 Study Success
An article belongs to this narrative if it discusses the Phase 3 results of Ultragenyx's DTX301 gene therapy.
MSI dividend history and yield
An article belongs to this narrative if it discusses the dividend history, yield, or expectations for Motorola Solutions (MSI).
Chinese investment in UK bioscience
An article belongs to this narrative if it covers Chinese investment in the UK's bioscience sector, such as Syngenta's new research center.
Xylem Q3 2024 earnings call
An article belongs to this narrative if it is about Xylem's Q3 2024 earnings call.
Crane Co crosses above 200-day moving average
An article belongs to this narrative if it discusses CR's stock performance and its 200-day moving average.
Cellebrite acquires Drone Forensics Leader SCG Canada
An article belongs to this narrative if it discusses Cellebrite's acquisition of Drone Forensics Leader SCG Canada.
Water utilities sector decline
An article belongs to this narrative if it discusses a decline in water utilities stocks as a sector.
Seaport Research maintains Nucor price target
An article belongs to this narrative if it discusses Seaport Research's price target for Nucor Corporation.
BSX EKOS System Successful Intermediate-Risk PE Treatment Trial
An article belongs to this narrative if it discusses Boston Scientific's EKOS Endovascular System trial results for treating intermediate-risk pulmonary embolism.
OHI stock outlook remains cautious
An article belongs to this narrative if it discusses the investment community's outlook on Omega Healthcare Investors, Inc. (OHI) stock.